We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Amyris Inc | NASDAQ:AMRS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.05 | 0.053 | 0.054 | 0 | 01:00:00 |
NEW YORK, Oct. 18, 2019 /PRNewswire/ -- WeissLaw LLP, a national class action and shareholders' rights law firm with offices in New York, Los Angeles and Atlanta, announces the investigation of Amyris, Inc. (NASDAQ: AMRS) ("AMRS," or the "Company"), its Board of Directors, and certain Company officers for, among other things, possible breaches of fiduciary duty and violations of federal securities laws.
If you are a shareholder of AMRS who wishes to discuss the investigation or have any questions about this notice and your rights or interests, visit our website:
http://www.weisslawllp.com/amyris-inc/
Or please contact:
Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888)593-4771
stockinfo@weisslawllp.com
On April 11, 2019, the Company filed with the SEC a form 8-K announcing that it would be issuing restatements for its financial results for the periods ended March 31, 2018 through September 30, 2018. AMRS attributed this to material errors made in connection with its revenue recognition practices, expenses, and in certain foreign currency transactions. As a result, the Company anticipated significant reductions in the earnings figures previously reported for those periods.
On that news, AMRS' share price dropped $1.51, or approximately 39%, from its April 10 trading price of $4.10 to trade for as low as $2.59 on the following day.
WeissLaw is investigating whether AMRS' Board breached its fiduciary duties to the Company and made materially false and/or misleading statements to shareholders by failing to ensure that an adequate system of internal controls was maintained over the Company's operations and financial reporting. If you wish to discuss this investigation or have any questions concerning this notice or your rights or interests, please contact Joshua Rubin of WeissLaw LLP at (888)593-4771, or by e-mail at stockinfo@weisslawllp.com.
WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients.
View original content to download multimedia:http://www.prnewswire.com/news-releases/weisslaw-llp-amyris-inc-is-the-subject-of-a-legal-investigation-300941390.html
SOURCE WeissLaw LLP
Copyright 2019 PR Newswire
1 Year Amyris Chart |
1 Month Amyris Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions